CLYDESDALE PHARMA LTD – MIA 51718
| Authorisation Number | UK MIA 51718 |
| Category | MIA |
| Holder | CLYDESDALE PHARMA LTD |
| Registered Address | CLYDESDALE PHARMA LTD, UNIT 3-5 CAMPBELL COURT, BRAMLEY, TADLEY, RG26 5EG, UNITED KINGDOM |
| Authorisation Date | May 28, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 1 |
| Manufacturing Operations | 1.2 1.2.1 1.2.1.1 1.2.1.11 1.2.1.12 1.2.1.13 1.2.1.14 1.2.1.2 1.2.1.3 1.2.1.5 1.2.1.6 1.2.1.8 1.2.1.9 1.2.2 1.6 1.6.3 |
| Importation Operations | 2.1 2.1.3 2.2 2.2.2 2.3 2.3.1 |
| MHRA Link | View on MHRA Website |
Sites (1)
CLYDESDALE PHARMA LTD
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.2 — Non-sterile products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.2 — Capsules, soft shell
1.2.1.3 — Chewing gums
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.8 — Other solid dosage forms
1.2.1.9 — Pressurised preparations
1.2.1.11 — Semi-solids
1.2.1.12 — Suppositories
1.2.1.13 — Tablets
1.2.1.14 — Transdermal patches
1.2.2 — Batch certification
1.6 — Quality control testing
1.6.3 — Chemical/Physical
Importation
2.1 — Quality control testing of imported medicinal products
2.1.3 — Chemical/Physical
2.2 — Batch certification of imported medicinal products
2.2.2 — Non-sterile products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
Content Preview
The source document is available on KeyPedia. Sign in to view.